SfEE expresses concerns on Greek market inspections findings

1 October 2018
greece_greek_big

The Greek pharma trade group SfEE says it read the recent news reports about illegal practices in the prescription and sale of medicines and other types of healthcare benefits, as revealed following the National Organization for Healthcare (EOPYY) inspections, with concern, almost indignation.

The SFEE obviously welcomes such efforts by the EOPYY and wishes that every source of unlawfulness and abuse be eradicated. At the same time, however, the SfEE says “it cannot but feel indignant at seeing that all areas of healthcare, pharmaceuticals in particular, are dominated by the logic of clawback, a logic that has led the state to shake off any responsibility for a rational management of available resources.”

Bringing pharma industry close to collapse

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical